EMA to introduce Public Hearings

Vox Populi at EMA’s PRAC

Public hearings are a new tool allowing the European Medicines Agency (EMA) to engage with European Union (EU) citizens in the supervision of medicines and listen to their views and experiences. EMA is preparing to hold public hearings at its Pharmacovigilance Risk Assessment Committee (PRAC) from as early as the fourth quarter of 2016.

Read the pdf
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /